Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.29 – $0.29
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $922.0M | $1.65B | $1.43B | $1.84B | $2.36B | $2.79B | $2.81B | $2.58B |
| Cost of revenue | $508.9M | $831.7M | $860.3M | $1.07B | $1.45B | $1.61B | $1.71B | $1.76B |
| Gross profit | $413.1M | $816.8M | $565.8M | $771.5M | $913.1M | $1.18B | $1.10B | $818.5M |
| Gross margin | 44.8% | 49.5% | 39.7% | 42.0% | 38.6% | 42.1% | 39.1% | 31.7% |
| R&D | $12.0M | $13.3M | $11.5M | $10.7M | $17.5M | $21.7M | $24.7M | $20.1M |
| Operating income | $276.9M | $530.0M | $237.7M | $371.4M | $285.4M | $480.5M | $453.9M | $197.9M |
| EBITDA | $319.1M | $642.5M | $331.9M | $494.1M | $476.2M | $682.0M | $725.6M | $538.6M |
| Net income | $166.6M | $409.6M | $251.6M | $339.9M | $121.1M | $344.7M | $283.1M | −$951.0M |
| Net margin | 18.1% | 24.8% | 17.6% | 18.5% | 5.1% | 12.4% | 10.1% | -36.8% |
| EPS (diluted) | 0.07 | 0.19 | 0.10 | 0.14 | 0.05 | 0.12 | 0.10 | -0.35 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.9B | $0.08 | $0.08–$0.09 | 1 |
| 2027 | $3.2B | $0.11 | $0.10–$0.12 | 1 |
| 2028 | $3.4B | $0.14 | $0.14–$0.15 | 1 |
Forward consensus · source: Financial Modeling Prep
JINXIN FERTILITY GRP LTD
No one on the platform currently holds JXFGF.
No tracked institution reports a position in JXFGF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-07-02 | $0.0418 | 2026-07-28 |
| 2024-07-02 | $0.0595 | 2024-07-25 |
No one on the platform has traded JXFGF yet.
| -10.79% |
| $1.6B |
| — |
| MCVEFMedicover AB (publ) | $27.25 | +0.00% | $4.1B | — |
| MCVEYMedicover AB (publ) | $16.55 | +0.00% | $2.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.